Synergy Pharma (SGYP) Tops Q1 EPS by 1c, Sales Miss; Guides Lower

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Synergy Pharma (SGYP) Tops Q1 EPS by 1c, Sales Miss; Guides Lower

Synergy Pharmaceuticals Reports First Quarter 2018 Financial Results and Business Update

May 10, 2018 4:15 PM EDT

TRULANCE only CIC/IBS-C Rx brand to grow in total and new Rx volume quarter-over-quarter, per IQVIA Synergy lowers 2018 adjusted operating expense (non-GAAP) guidance Initiated strategic partnership with the National Cancer Institute (NCI) to collaborate on study to evaluate dolcanatides potential to prevent colorectal cancer Conducting ongoing review of strategic business development options focused on maximizing shareholder value

NEW YORK--(BUSINESS WIRE)-- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the... More